Back to School: How biopharma can reboot drug development. Access exclusive analysis here

MediciNova raises $44 million

MediciNova (San Diego, Calif.) raised $44 million in a series C round

Read the full 127 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE